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The MDRi gcnc. considered 10 bc involved in muhidruy rcsis1uncc oI’c:mccr cells. is cxprcsscd in liver. kidney. small intcstinc and the blood-brain 
burricr. Wc investigated MDR/ gent cxprcssion in ~lru \vull-dirl’crcnliulcd hupatoma cell linr! HcpGZ after cxposurc IO scvcral stresses and round 
thn1 sodium urscnilc ircamcnt incrcascd MDRi ycnc cxprsssion 2.6.fold. Delciion unulysis ol’thc MDRI promoicr indicdtd lha1 the 1ronscripiional 
uclivulion uflcr c%posllrc lo iwscllilt dcpciids on :I 60-bp region coniuininy 1~0 heal-shock responsive clcmcnls. 
Muhidrug rcsisiuncc: AIDRI: P-Glycoproicin: Hcui-shock proicin 
I. INTRODUCTION 2. MATERIALS AND METHODS 
Acquisition of multidrug resistance of cancer cells is 
a big obstacle in chemotherapy. The development 01 
multidrug resistance (two- to severalfold) in cultured 
cells is initially accompanied by elevated expression of 
the MDRi gene, which codes for P-glycoprotcin. with- 
out gene amplification [I]. During further selection for 
increased levels of resistance, expression of MDA1 
mRNA is extraordinarily increased simultaneously with 
amplification of the MDRl gene. However because no 
amplification of the MDRI gene has been reported in 
clinical samples, the mechanism of aiyuii’ing low levels 
of resistance accompanied by a moderate increase of 
MDRI expression without gene amplification is not 
known. Recently Chin et al. reported that exposure of 
a renal adcnocarcinoma cell line to heat shock or so- 
dium arsenite increased MDRI mRNA levels [2]. In this 
report, we show that the expression of the MDRI gem 
in a hepatocarcinoma cell line, HepG2, was increased 
by exposure to sodium arsenite and that this response 
dependend on a promoter region containing a tandem 
repeat of heat-shock responsive lements (HSEs). 
.4hhrzGGurrs: HSE. heat-shock rcsponsivc clcmuni; TPA. I?-0-icira- 
dccanoylphorbol-l3accia1c; CAT. chlorumphcnicol acc1yltrunsl’crusc 
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Plusmid pSVOOCAT [3;1, pBI.CAT? [ill. p;~ct-/?-giul. and LSNWT [S] 
wcrs provided by Dr. E. Araki. Dr. B. Luckow. Dr. S. Ishii. and Dr. 
R.I. Morimoto, rcspcctivcly. 
A pun of MbRI cDNA. pMDRSA [6]. wus used iis a probe. Tolvl 
RNAs cxlrucicd rrom cells wcrc 1rtinst’crrcd 10 GcnoScrccn Plus (Du 
Ponl). Hybridiwiions wcrc done ai 60°C for I6 h in I% SDS. I M 
NaCI. 10% dcxtran sulFa. and 100pg/ml or’dcnuturcd salmon sperm 
DNA. Filters were wushcd 10 a final siringcncy ol2&?iCund 1% SDS 
ilt 6iJ”C, Compar;iblc RNA lotiding was conlirmcd using D human 
&ac1in probe [7]. Ribonucleusc protection assays wcrc done as dc. 
scribed using probe PN [8]. 
A lhrcc-kilobrscpair rragmcnt oon&ing the MDA1 prornotcr rc- 
pion. the firs1 cxon. firs1 iniron. scrond cxon. and u par1 ofthc second 
intros [8] was excised from the 3’ terminal using cxonucleuse III and 
mungbcun nuclcusc. The dclcicd promoter from the 3’tcrminul to the 
sixth nucloolidc of the second cxon (the firsi ATG codon s1uning from 
the scvcnth nuclcotidc was cxciscd) wus cloned in10 pSVOOCAT 
(pMPICAT). pMPlCAT wus cxciscd from the 5’1crminul10construc~ 
pMPSCAT, pMP6CAT nnd pMP8CAT (Fig. 3). 
IO ,~g of plusmid DNA wus trunsl&tcd into HcpG2 with 51s ofthc 
imcrnal control plusmid. pnct+gal. which carries 1hc&ulactosidasc 
gcnc under the con1rol or the chicken fi-actin promoter 191. using ihc 
culcium phospha1c coprccipitation method us previously described 
[IO]. Cells wcrc cxposcd IO 100 PM of sodium arscnilc 96 h ulicr lhc 
iransr’uciion because DNA 1ranrfazlion and glycerol shock muy CIUSC 
some s1ress. Aciually. whw cells wcrc cxposcd IO sodium arscniic 48 
h ulier 1hc tran&cGon of LSNWT containing the CAT gcnc under 
ihc control of 1hc irsj170 promour. no signilican~ incrcasc in CAT 
uctivity wus dclcacd (data noI shown). Cells wcrc ircaicd with sodium 
urscnhc for 4 h. Cell cxlracts which showed rhc sumc~-pluciosidusc 
activhy wcrc added LO Ihc usssy solution containing 100 mM Tris- 
HCI. pH 7.8. I mM chlorumphcnicol. and I .85 kBq of [‘JC]bulyryl 
coenrymc A. The rcruclion mixture was gcnlly overlaid with 5 ml ol’ 
EconolIuor und ihcn incubated ill 37°C. A1 3u-min inurvuls. indi- 
vidual vials wcrc counicd for 0. I min. The CAT ucliviiics wcrc com- 
pared ui the time whcrc all the s;impla show linuiirily over lime. 
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Fig. I. Induction of MDRI mRNA expression in HepG2. Panel (A,B): slot blot hybridization. 12 pg of total cellular RNA and twofold serial 
dilutions were put on GeneScreen plus and hybridized with probe SA us described in Materials and Methods (A). 2 ~(8 of RNA were hybridized 
with a human/Y-a&n probe as a control (B). Total RNA from HepG? (lune I), treated with 300yM H?O, for I h (lar.c 2). IOOpM sodium arscnitc 
for 4 h (lane 3), 30 ng/ml TPA for 30 min (lunc 4). 12.5 @ml adriamycin for 24 h (lane 5). heut shock at 4S°C for.,.10 min (lane 6). Trealmenl 
with drugs were followed by recovery in fresh medium for 3 h. The heat shock was followed by rccovcry at 37°C for 4 h. Panel (C): ribonuclease 
protection assay. Total RNAs (IOpg) extracted from HcpG2 before (l~nc I). und al’tcr urscnitr treatment at 100 ,uM for 4 h (lane 2), from drug 
sensitive KB3-1 (Line 3), and from drug-resistant KB8-S (lane 4) were analyzed by ribonuclearc protefGon as dcscribcd in Materials und Methods, 
The IM-nuclcotide fragment is the transcript from the major initiation site arthc downstream promoter [8]. The 550.nucleotidc fragmem in lane 
2 is considered to be the nascent ranscript (splicing intermediate) from the downstream promolcr, The 323.nucleolidc frngmcnt in lane 4 is the 
transcript from the upstream promoter [8], The numbers on the right indicutc nucleotidc numbers oflhc prolectcd fraCmcnts. Slot blot hybridization 
and rihonuclease protection assuy were done twice. 
-323 
3. RESULTS 
3.1. Effects of stress on MDRI expressiotz 
MDA1 is expressed in human normal liver and is 
believed to act as a secretory pump for physiological 
metabolites and natural toxic substances in the diet [I I], 
and the expression of the rodent mr/r gene is elevated in 
chemically induced preneop!r?stic and neopiastic liver 
nodules [12,13]. To investigate whether stress and cyto- 
toxic agents have any effects on MDRI expression in 
human liver cells, we used a well-differentiated human 
hepatocarcinoma cell line, HepG2. The slot blot hy- 
bridization of total RNA showed that when HepG2 was 
treated with sodium arsenite at 100 AM for 4 h, about 
a twofold increase of MDA? mRNA was observed (Fig. 
1 A, lane 3). A ribonuclease protection assay (Fig. 1 C) 
and densitometric scanning indicated that MDRI 
mRNA increased 2,6-fold, ‘The level of&actin mRNA 
did not change after exposure to sodium arsenite (Fig. 
irjlj. Heat shock at 4% For i0 min roiiowrj lay t-r- 
covery at 37°C for 4 h had a marginal effect on the level 
of MDRf mRNA (Fig. 1 A, lane 6). Heat shock at 42°C 
for 1 h or 2 h scarcely affected it, either (data not 
shown). Some stress proteins are inciuced by DNA- 
damaging agents [14], but no significant increase of 
MDRI expression was observed after exposure LO 
hydrogen peroxide (lane 2), 4-nitroquinoline-N-oxide, 
or N-methyl-iV’-nitro-Rnitrosoguanidine (data not 
shown). Adriamycin or TPA did not increase MDRl 
mRNA, either (lanes 5 and 4) 
3.2. ittvolvetmwr of HSE seq~re~ms itz rltr itrductiott 
The human MDRl gene has two promoters, the up- 
stream and the downstream. Normal tissues, renal cell 
carcinomas, colon adenocarcinomas, HepG2, and 
vinblastine-selected KB multidrug-resistant ceils mainly 
use the downstream promoter [6,8,10]. But the up- 
stream promoter is also active in coichicine-selected KB 
multidrug-resistant cells and some clinical samples 
[10,15]. A ribonuclease protection assay using the first 
exon indicated that the transcript from the downstream 
promoter increased when HepG2 cells were treated with 
sodium arseniie (Fig. IC). To identify the sequence in- 
volved in the increase of MDRI mRNA after exposure 
lo sodium srsenite, CAT assay analysis was done using 
pMPiCAT, which contains the downstream promoter 
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Fig. 2, Schematic representation or MDRI promoter deletions. 
pMPlCAT contains the MDRI genomic IIagmcnt spanning from 
-1073 to -703 compared to the major transcription initiation site, 
which consists of 1073 bp or the upstream scqucncc, 131 bp or the 
non-coding first cxon. 562 bp of the Arst intron. and u part (6 bp) OC 
the second cxon, Open boxes indicate the CAT gcnc in pSVOOCAT 
and filled boxes indicate the first cxon and a par1 of the second exon 
or the MDRl gem. The numbers arc presented with the major triin- 
scription initiation site as +I. HSE. heat-shock rcsponsivc lement: 
CAAT. CAAT box; GC, GC box. 
of the MDRl gene isolated from normal human tissue 
[S] (Fig. 2). When HepG2 cells were treated with 100 
yM of sodium arsenite 96 h after the transfection of 
pMPlCAT. the CAT activity increased 2.3-fold (Table 
I). The CAT activity of an extract from cells transfccted 
with pBLCAT2, which contains the CAT gene under 
the control of the tk promoter, did not change after 
exposure to arsenite. The 2.3-fold increase in the pro- 
moter activity of MDRl was significant because the 
ltsp70 promoter in LSNWT showed no more than a 
2.1 -fcld increase after exposure to arsenite under our 
conditions. 
A series of deletion mutants from pMPlCAT (Fig. 2) 
was examined by the CAT assay. Because pMPSCAT 
had a similar promoter activity to pMP1CAT (Tahlc I), 
sequences from - 1073 to - 106 including HSEs and the 
CAAT box may not be significant for the basal pro- 
Table 1 
Promoter activity of deletion constructs in HcpG2 
CAT activity’ 
-arscnite +arscnitc 
Foldh 
increase 
pMPlCAT 28 65 2.3 (0.59) 
pMP5CAT 33 61 I.8 (0,351 
pMP6CAT 59 65 I.1 (0.27) 
pMP8CAT 34 32 0.94 (0.28) 
pSVOOCAT 0 0 
pBLCAT2frk) 100 96 0.96 (0.16) 
LSNWT;h,sp70) 63 132 2.1 (0.45) 
“CAT aclivity is the percent ratio rclativc to the CAT activity of 
pDLCAT2 without arscnitc treatment. Each value is the average of 
at least four experiments. Plusmic carrying the &g;llactosidase gene 
cDNA under the controi oTtlie&~ctin promoler was cotranskled, 
and the /%galactosidnsc a tivity of cell extracts were used as an 
inlcrnal control. 
“Values in parentheses are the siundard deviations. 
moter activity in HepG2. The promoter activity of 
pMP5CAT (- 193 to +704) was increased 1.8-fold after 
exposure to arsenite, but that of pMP6CAT (-132 to 
+704) or pMP8CAT (-106 to +704) was not. These 
results suggest hat the nucleotide sequence from -193 
to - 133, which contains a tandem repeat of HSEs 
(-174 CCAGAACAECTC -161 and -161 CCT- 
GGAAX-g -m), is%cessary for the irduc- 
tionby arsenite treatment. 
4. DISCUSSION 
We have shown here that sodium arsenite treatment 
increases the MDRl mRNA expression in the hepato- 
carcinoma cell line HepG2. We also observed that 
MDRI gene expression was increased after exposure to 
sodium arsenite in HeLa and monkey CV-I cells (data 
not shown). The increase OF MDRl mRNA could be 
mediated by either transcriptional ctivation or mRNA 
stabilization or both. A CAT assay using pMPlCAT 
indicated that sodium arsenite activated the MDRI pro- 
moter. A nuclear run-on assay using CV-1 indicated 
that arsenite treatment activated the transcription of the 
monkey m&f gene (data not shown). These results ug- 
gested that at least a part of the increase of mRNA is 
mediated by transcriptional activation. 
Deletion analysis of the MDRI promoter indicated 
that the transcriptional ctivation depended on a 60-bp 
region (- 193 to - 133) containing two HSEs, one (- 174 
to -161) is a 7/8 match and the other (-161 to -148) 
a 618 match. In addition, the accumulation of MDRI 
mRNA after exposure to arsenite was inhibited by quer- 
cetin (Kioka. N., submitted). This result also supports 
the involvement of HSEs in the induction of the MDA1 
gene expression, because quercetin interacts with heat 
shock factor to inhibit the induction of the heat shock 
response (Nagata, K., personal communication). 
We could not detect a significant increase of the 
MDRI gene expression in HepG2 after heat shock. Re- 
cently, Chin et al. reported that MDRI mRNA in two 
human renal carcinoma cell lines, HTB44 and HTB46, 
was increased by arsenite treatment or heat shock [2]. 
The reason that the induction of the MDRI gene by 
heat shock was detected only in these two renal carci- 
noma cell lines is unclear. The basal expression of the 
MDR! gene was quite low in HTB44 and HTB46 com- 
pared to KBS-5 [2]. The MDRI gene cxpiession in 
HepG2 is comparable to that in KB8-5 (Fig. 2). Because 
of the substantial expression in HepG2, the induction 
of MDA1 expression by heat shock might not be de- 
tected under our conditions. Alternatively the MDRI 
gene might be regulated in a cell-type specific manner. 
Although the conditions under which the MDRI gene 
expression is regulated are to be examined in more de- 
tail, the MDRl gene-is clearly induced under certain 
stress conditions. A twofold increase of P-glycoprotein 
expression in cancer cells is supposed to be critical in 
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chemotherapy. The identification of the sequence in- 
volved in the induction of MDRI expression will facil- 
itate the approach to modify P-glycoprotein expression 
to conquer multidrug resistance. 
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